SAN CARLOS, Calif., Nov. 21, 2016 /PRNewswire/ -- Savant HWP, Inc., today issued a comment on the report issued by the U.S. Surgeon General on the United States' drug and alcohol abuse crisis, Facing Addiction in America:
"We commend the Surgeon General for issuing this comprehensive report, which has the potential to change the way that substance use disorders are viewed, from a 'moral failing' to a 'chronic disease of the brain that is deserving of compassion and care'," said Stephen L. Hurst, President and CEO of Savant HWP, Inc. "Savant has been working since 2009 to develop a transformational medicine to aid in the treatment of drug dependency and addiction by restoring normal brain functions to those deeply affected by drugs, alcohol or nicotine. We greatly welcome this effort to change how the growing problem of addiction is regarded and to encourage more support for new approaches to treating this growing health epidemic."
About Savant HWP, Inc.
Savant HWP ("Savant") develops pharmaceutical products that alleviate suffering by improving health, maintaining wellness and preventing disease. We identify opportunities to create innovative products in areas where our work has the greatest impact, including smoking cessation, other substance use disorders and neglected diseases that are emerging in the U.S. and endemic in other parts of the world, such as leishmaniasis. For more information, please visit our website at http://www.savanthwp.com.
SOURCE Savant HWP, Inc.